2023
DOI: 10.1016/j.cell.2023.03.029
|View full text |Cite
|
Sign up to set email alerts
|

KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 30 publications
(36 citation statements)
references
References 84 publications
0
34
0
Order By: Relevance
“…To our surprise, sgChr20-3 induced 9.2% losses and 18.5% gains in chr2 (p < 0.001), which we may not have observed if we had instead evaluated the gRNA using a chromosome-targeted method such as fluorescence in situ hybridization rather than a genome-wide method. The sgChr20-3 sequence matches 18 out of 20 base pairs for sites on the chr2 centromere 12 , suggesting an explanation of the off-target effect. These data indicate that our panel can be used to efficiently screen CRISPR genome engineering methods like KayroCreate and successfully use gRNA detection to multiplex samples.…”
Section: Resultsmentioning
confidence: 87%
See 2 more Smart Citations
“…To our surprise, sgChr20-3 induced 9.2% losses and 18.5% gains in chr2 (p < 0.001), which we may not have observed if we had instead evaluated the gRNA using a chromosome-targeted method such as fluorescence in situ hybridization rather than a genome-wide method. The sgChr20-3 sequence matches 18 out of 20 base pairs for sites on the chr2 centromere 12 , suggesting an explanation of the off-target effect. These data indicate that our panel can be used to efficiently screen CRISPR genome engineering methods like KayroCreate and successfully use gRNA detection to multiplex samples.…”
Section: Resultsmentioning
confidence: 87%
“…To demonstrate the combined copy number detection and multiplexing capabilities of our system, we tested it on samples treated with KaryoCreate, a method we recently developed to induce chromosome-specific aneuploidy in cultured cells 12 . KaryoCreate uses CRISPR gRNAs to target a mutant KNL1-dCas9 fusion protein to the centromere of a specific chromosome, causing missegregation in ∼20% of cells.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The fact that we observed GFPpositive bridges during anaphase in ∼ 30% of the RPE1-dCas9-Kin14VIb cells transduced with the Chr9-cen sgRNA, but without Kin14VIb binding to the repeat, underscores this notion. We consider it likely that the mere binding of dCas9 to the recently published centromere-specific repeats induces similar replication issues (Bosco et al, 2023). Importantly, the inducible FKBP12-FRB dimerization modality and the presence of a NES in Kin14VIb enabled a direct assessment of the consequence of Kin14VIb motor binding to a chromosome of interest during mitosis.…”
Section: Opportunities and Limitations Of The Approachmentioning
confidence: 85%
“…KaryoCreate (karyotype CRISPR‐engineered aneuploidy technology), a method that allows the production of chromosome‐specific aneuploidies in human cells, was recently developed (Bosco et al ., 2023). Its foundation is the use of dCas9 coupled to mutant KNL1 to target chromosome‐specific CENPA‐binding satellite repeats.…”
Section: A Bright Future For Plant Chromosome Engineeringmentioning
confidence: 99%